Capital Fund Management S.A. lowered its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 49.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,430 shares of the financial services provider's stock after selling 26,945 shares during the period. Capital Fund Management S.A. owned about 0.06% of Trupanion worth $1,322,000 at the end of the most recent reporting period.
Other large investors have also made changes to their positions in the company. Baillie Gifford & Co. lifted its holdings in Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock worth $33,806,000 after buying an additional 147,341 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Trupanion by 458.3% during the 4th quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider's stock valued at $7,620,000 after purchasing an additional 129,782 shares in the last quarter. Invesco Ltd. lifted its position in shares of Trupanion by 122.0% during the 4th quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider's stock valued at $10,925,000 after acquiring an additional 124,549 shares during the last quarter. Trexquant Investment LP lifted its position in shares of Trupanion by 229.3% in the 4th quarter. Trexquant Investment LP now owns 138,109 shares of the financial services provider's stock valued at $6,657,000 after acquiring an additional 96,174 shares in the last quarter. Finally, Hosking Partners LLP boosted its stake in shares of Trupanion by 52.5% during the 4th quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider's stock valued at $10,253,000 after buying an additional 73,203 shares during the period.
Analysts Set New Price Targets
Several analysts have issued reports on TRUP shares. Stifel Nicolaus decreased their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research report on Thursday, February 20th. Piper Sandler decreased their price objective on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $46.60.
Read Our Latest Stock Report on TRUP
Insider Transactions at Trupanion
In other news, insider Brenna Mcgibney sold 5,000 shares of the company's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $164,950.00. Following the sale, the insider now directly owns 3,738 shares in the company, valued at approximately $123,316.62. This represents a 57.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the sale, the chief executive officer now owns 118,784 shares in the company, valued at approximately $4,415,201.28. The trade was a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 29,792 shares of company stock worth $989,442 over the last three months. 5.50% of the stock is currently owned by company insiders.
Trupanion Stock Performance
Shares of TRUP stock traded down $1.86 during trading on Monday, reaching $32.86. 82,901 shares of the company's stock traded hands, compared to its average volume of 651,863. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90. The firm's 50-day moving average is $36.71 and its 200 day moving average is $45.58. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $1.40 billion, a P/E ratio of -143.40, a PEG ratio of 6.02 and a beta of 1.66.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Equities research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.